J&J starts head-to-head PFA trial against Boston Scientific device
This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free…
Eli Lilly to acquire cancer drug maker Kelonia in deal worth up to $7B
Eli Lilly will acquire biotech company Kelonia Therapeutics in a deal worth up to $7 billion, the company…
Johnson & Johnson Vs. Pfizer
As large tech companies struggled this year, investors have had a chance to reevaluate their portfolios and identify…
How The Narrative On Johnson & Johnson (JNJ) Is Shifting With New Targets And Litigation Risks
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply…
ICOTYDE Approval Adds New Growth Angle To Johnson & Johnson Valuation Story
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million…
FDA accepts BMS protein degrader for review; Disc rare disease drug rejected
This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free…
More drugs should be over-the-counter
Food and Drug Administration Commissioner Marty Makary told CNBC that he believes “everything should be over the counter”…
Is Johnson & Johnson a Buy, Sell, or Hold in 2026?
While artificial intelligence (AI) stocks are dominating debates and headlines on Wall Street, companies in other sectors can…
Robotic surgery fuels Johnson & Johnson dividend growth outlook
Johnson & Johnson (JNJ) just made a move that investors have been waiting years to see. The healthcare…
Johnson & Johnson (JNJ) Q4 earnings
Johnson & Johnson said on Thursday that it has reached an agreement with the U.S. President administration to…
Retiring at 64 With $2.1 Million Means Navigating a $10,500 Annual Gap Nobody Talks About
JU.STOCKER / Shutterstock.com A 3.9% withdrawal rate yields $81,900 annually but dividend income only covers $73,500. Medicare Part…
The GLP-1 Blockbuster Maker Widens Its Lead as the Diversified Healthcare Giant Posts Steady Growth
jetcityimage / iStock Editorial via Getty Images Lilly posted 53.9% revenue growth and 480% net income growth driven…